Stock listing
KRX:145020 Hugel, Inc. (휴젤) 주가
Follow Hugel, Inc. into a list and get an email when it puts out news.
Share price · KRX:145020
₩206,500 KRW +8,000 (+4.0%)
Close on Nov 20, 2026
- Day range
- ₩204,500 – ₩214,500 KRWNov 20, 2026
- Volume
- 75,242 sharesNov 20, 2026
- Market cap
- ₩2.23T KRWAt the close on Nov 20, 2026 · price × 10.80M shares outstanding
- 52-week range
- ₩163,700 – ₩308,500 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- ₩10.33B KRWMedian day 42,829 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:145020 · KRW, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| ₩206,500 | +8,000 | +4.0% | ₩210,000 | ₩214,500 | ₩204,500 | 75,242 | |
| ₩198,500 | +5,900 | +3.1% | ₩192,500 | ₩202,000 | ₩192,500 | 74,320 | |
| ₩192,600 | +200 | +0.1% | ₩191,700 | ₩195,200 | ₩190,400 | 59,282 | |
| ₩192,400 | +100 | +0.1% | ₩193,100 | ₩194,900 | ₩187,600 | 43,313 | |
| ₩192,300 | -4,100 | -2.1% | ₩196,500 | ₩202,000 | ₩191,500 | 42,876 | |
| ₩196,400 | +900 | +0.5% | ₩194,100 | ₩199,700 | ₩190,600 | 60,029 | |
| ₩195,500 | -3,800 | -1.9% | ₩198,900 | ₩201,000 | ₩192,800 | 54,775 | |
| ₩199,300 | +12,200 | +6.5% | ₩189,500 | ₩201,500 | ₩188,200 | 64,770 | |
| ₩187,100 | -400 | -0.2% | ₩186,600 | ₩190,900 | ₩179,500 | 44,631 | |
| ₩187,500 | 0 | 0.0% | ₩181,000 | ₩193,000 | ₩178,400 | 102,777 | |
| ₩187,500 | +3,500 | +1.9% | ₩186,100 | ₩194,500 | ₩186,100 | 84,943 | |
| ₩184,000 | -5,500 | -2.9% | ₩189,600 | ₩191,000 | ₩167,400 | 120,209 | |
| ₩189,500 | +6,500 | +3.6% | ₩181,200 | ₩191,700 | ₩180,600 | 62,830 | |
| ₩183,000 | +3,200 | +1.8% | ₩179,800 | ₩183,900 | ₩178,300 | 30,816 | |
| ₩179,800 | -3,500 | -1.9% | ₩182,400 | ₩183,000 | ₩177,000 | 35,682 | |
| ₩183,300 | +1,800 | +1.0% | ₩183,200 | ₩183,600 | ₩178,000 | 42,782 | |
| ₩181,500 | +2,100 | +1.2% | ₩179,400 | ₩183,000 | ₩179,400 | 25,862 | |
| ₩179,400 | +3,000 | +1.7% | ₩178,100 | ₩184,900 | ₩177,300 | 40,313 | |
| ₩176,400 | -3,700 | -2.1% | ₩177,000 | ₩180,800 | ₩175,900 | 24,338 | |
| ₩180,100 | -700 | -0.4% | ₩180,500 | ₩182,000 | ₩176,600 | 58,676 | |
| ₩180,800 | -5,000 | -2.7% | ₩186,300 | ₩186,400 | ₩180,300 | 43,616 | |
| ₩185,800 | +1,600 | +0.9% | ₩184,600 | ₩188,900 | ₩184,600 | 36,635 | |
| ₩184,200 | -2,800 | -1.5% | ₩184,500 | ₩190,100 | ₩182,800 | 49,794 | |
| ₩187,000 | +7,900 | +4.4% | ₩179,800 | ₩187,000 | ₩177,000 | 40,163 | |
| ₩179,100 | +10,600 | +6.3% | ₩168,700 | ₩182,000 | ₩168,700 | 66,506 | |
| ₩168,500 | -4,000 | -2.3% | ₩167,500 | ₩170,900 | ₩163,700 | 43,550 | |
| ₩172,500 | +2,600 | +1.5% | ₩171,300 | ₩177,000 | ₩171,000 | 46,666 | |
| ₩169,900 | -10,100 | -5.6% | ₩179,100 | ₩179,300 | ₩164,100 | 68,154 | |
| ₩180,000 | -2,800 | -1.5% | ₩181,900 | ₩182,400 | ₩179,400 | 64,190 | |
| ₩182,800 | -800 | -0.4% | ₩183,900 | ₩184,400 | ₩179,400 | 54,306 | |
| ₩183,600 | +2,100 | +1.2% | ₩182,400 | ₩186,100 | ₩182,200 | 32,479 | |
| ₩181,500 | +1,400 | +0.8% | ₩180,100 | ₩182,900 | ₩178,900 | 57,448 | |
| ₩180,100 | -500 | -0.3% | ₩180,600 | ₩183,700 | ₩179,400 | 39,279 | |
| ₩180,600 | +900 | +0.5% | ₩178,200 | ₩181,000 | ₩175,500 | 65,544 | |
| ₩179,700 | -3,600 | -2.0% | ₩184,400 | ₩185,500 | ₩178,700 | 47,092 | |
| ₩183,300 | -2,800 | -1.5% | ₩180,900 | ₩189,000 | ₩178,600 | 102,069 | |
| ₩186,100 | -900 | -0.5% | ₩187,700 | ₩190,800 | ₩182,300 | 85,822 | |
| ₩187,000 | -3,400 | -1.8% | ₩189,900 | ₩191,300 | ₩185,900 | 42,222 | |
| ₩190,400 | -15,600 | -7.6% | ₩205,000 | ₩205,500 | ₩188,200 | 204,511 | |
| ₩206,000 | -8,000 | -3.7% | ₩212,500 | ₩213,500 | ₩205,000 | 77,391 | |
| ₩214,000 | -17,500 | -7.6% | ₩232,000 | ₩233,500 | ₩212,500 | 164,420 | |
| ₩231,500 | +500 | +0.2% | ₩231,500 | ₩232,000 | ₩228,000 | 29,436 | |
| ₩231,000 | -4,500 | -1.9% | ₩232,500 | ₩234,500 | ₩227,500 | 28,519 | |
| ₩235,500 | +3,500 | +1.5% | ₩229,500 | ₩238,500 | ₩229,500 | 37,807 | |
| ₩232,000 | +1,000 | +0.4% | ₩228,500 | ₩234,500 | ₩225,500 | 31,158 | |
| ₩231,000 | -5,000 | -2.1% | ₩229,500 | ₩235,000 | ₩229,000 | 32,932 | |
| ₩236,000 | 0 | 0.0% | ₩235,000 | ₩236,000 | ₩227,500 | 41,740 | |
| ₩236,000 | -2,000 | -0.8% | ₩236,500 | ₩238,500 | ₩234,500 | 24,658 | |
| ₩238,000 | -5,000 | -2.1% | ₩243,500 | ₩244,500 | ₩237,500 | 22,715 | |
| ₩243,000 | -1,000 | -0.4% | ₩245,000 | ₩245,000 | ₩241,000 | 11,435 | |
| ₩244,000 | +3,500 | +1.5% | ₩243,000 | ₩245,000 | ₩240,500 | 27,884 | |
| ₩240,500 | -5,000 | -2.0% | ₩247,500 | ₩251,000 | ₩239,000 | 30,768 | |
| ₩245,500 | +500 | +0.2% | ₩242,000 | ₩251,500 | ₩237,000 | 35,698 | |
| ₩245,000 | -7,000 | -2.8% | ₩249,500 | ₩250,500 | ₩242,500 | 24,852 | |
| ₩252,000 | -7,000 | -2.7% | ₩257,000 | ₩257,000 | ₩246,000 | 39,313 | |
| ₩259,000 | +13,500 | +5.5% | ₩244,500 | ₩262,000 | ₩244,500 | 54,163 | |
| ₩245,500 | -5,000 | -2.0% | ₩247,500 | ₩252,000 | ₩244,500 | 20,894 | |
| ₩250,500 | +2,000 | +0.8% | ₩245,500 | ₩252,500 | ₩245,500 | 21,741 | |
| ₩248,500 | -2,000 | -0.8% | ₩248,500 | ₩251,000 | ₩241,250 | 19,862 | |
| ₩250,500 | +5,500 | +2.2% | ₩243,000 | ₩256,000 | ₩243,000 | 37,596 | |
| ₩245,000 | -4,000 | -1.6% | ₩243,000 | ₩247,000 | ₩238,000 | 27,715 | |
| ₩249,000 | +2,000 | +0.8% | ₩249,000 | ₩251,500 | ₩243,000 | 34,361 |
Splits
1 split · KRX:145020 · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 3-for-1 | Split |
- Ticker
- KRX:145020
- Asset type
- Stock
- Sector
- Health care
- Industry
- Pharmaceuticals
- Exchange
- KRX
- Currency
- KRW
What changed lately
Latest news release · May 7, 2026
Hugel reports record Q1 earnings, driving strong global growth in aesthetics
Latest deck · Jan 15, 2026
J.P. Morgan Healthcare Conference 2026
Conference · 19 slides
Latest news
Hugel reports record Q1 earnings, driving strong global growth in aesthetics
May 7, 2026
Closed ₩259,500 (+1.8%) on May 7, 2026
Hugel to enter ECM-based injectable market with aesthetic portfolio expansion
Mar 31, 2026
Closed ₩257,000 (+6.9%) on Apr 1, 2026
Hugel, Inc. on 6ix
- Sector
- Health care
- Industry
- Pharmaceuticals
- News releases
- 2 in the last 12 months · 9 in all · newest May 7, 2026 · oldest 2025
- Decks
- 2 decks · latest Jan 15, 2026
Valuation
P/E 14.1× against a median of 18.1×: 5th lowest of 9 Pharmaceuticals companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- ₩1.62T KRW
- P/E
- 14.1×
- EV/sales
- 3.4×
- EV/EBITDA
- 7.1×
- Price/book
- 2.1×
- Gross margin
- 77.9%
- Operating margin
- 43.6%
- Net margin
- 32.9%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Pharmaceuticals: the 10 companies nearest in size, of 492 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Hugel, Inc. · KRX:145020 | US$1.66B | US$1.21B | 14.1× | 3.4× | 7.1× | 2.1× | 32.9% | 0.0× | n/a |
| Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE | US$1.68B | US$2.60B | n/a | 3.6× | n/a | n/a | −71.8% | n/a | 1.35 |
| Supernus Pharmaceuticals, Inc. · NASDAQ:SUPN | US$1.67B | US$1.85B | 3.7× | 1.4× | n/a | n/a | 32.9% | n/a | 0.67 |
| Caplin Point Laboratories Limited · NSE:CAPLIPOINT | US$1.66B | US$1.56B | 23.2× | 6.3× | 18.1× | 4.3× | 29.1% | 0.0× | n/a |
| AstraZeneca Pharma India Limited · NSE:ASTRAZEN | US$1.66B | US$1.60B | 86.8× | 5.7× | 59.3× | 17.5× | 6.8% | 0.0× | n/a |
| Agios Pharmaceuticals, Inc. · NASDAQ:AGIO | US$1.65B | US$1.05B | n/a | 7.4× | n/a | 1.7× | −264.8% | 0.0× | 1.10 |
| Faes Farma, S.A. · BME:FAE | US$1.65B | US$1.93B | 11.0× | 1.7× | 5.8× | 1.9× | 13.1% | 0.5× | n/a |
| Consun Pharmaceutical Group Ltd. · HKEX:1681 | US$1.64B | US$1.06B | 10.1× | 2.1× | 5.6× | 2.3× | 31.6% | 0.1× | n/a |
| BrightGene Bio-Medical Technology Co. Ltd. Class A · SSE:688166 | US$1.63B | US$1.68B | 106× | 8.3× | n/a | 3.5× | 7.6% | 0.5× | n/a |
| Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A · SZSE:002399 | US$1.62B | US$986.2M | 57.0× | 1.3× | n/a | 0.9× | 3.7% | 0.0× | n/a |
| NATCO Pharma Limited · NSE:NATCOPHARM | US$1.62B | US$1.62B | 13.1× | 4.3× | 14.2× | 1.6× | 32.8% | 0.0× | n/a |
| Median of the others | US$1.65B | US$1.61B | 18.1× | 3.9× | 14.2× | 2.1× | 10.3% | 0.0× | 1.10 |
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 281777.78 KRW · Analysts' mean
- EPS, year to Dec 2026
- 10467.85 · 12 analysts
- Revenue, year to Dec 2026
- 494.3B · 15 analysts
Team and board
| Officer | Role |
|---|---|
| Carrie Strom | Chief Executive Officer |
Events
- Next results
- Feb 10, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Quarter to Sep 30, 2026 | Nov 12, 2026 · After close | −2.1% |
| Q2 2026 | Aug 14, 2026 | −5.5% |
| Q1 2026 | May 7, 2026 · Before open | +1.8% |
| Q4 2025 | Mar 19, 2026 · Before open | −2.8% |
| Q3 2025 | Nov 14, 2025 · Before open | 0.0% |
| Q2 2025 | Aug 14, 2025 · Before open | −0.3% |
| Q1 2025 | May 8, 2025 · Before open | +2.4% |
| Q4 2024 | Mar 21, 2025 · Before open | +1.2% |
| Q3 2024 | Nov 14, 2024 · Before open | +3.8% |
| Q2 2024 | Aug 14, 2024 | +5.6% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · After close | −4.5% |
| Q4 2023 | Mar 21, 2024 · Before open | −2.3% |
| Q3 2023 | Nov 14, 2023 · Before open | +3.6% |
| Q2 2023 | Aug 11, 2023 · Before open | −2.1% |
| Q1 2023 | May 15, 2023 · Before open | −1.1% |
| Q4 2022 | Feb 9, 2023 · Before open | +3.9% |
| Q3 2022 | Nov 14, 2022 · Before open | −3.6% |
| Q2 2022 | Aug 16, 2022 · Before open | −4.8% |
| Q1 2022 | May 16, 2022 · Before open | −2.1% |
| Q4 2021 | Mar 17, 2022 · Before open | +5.4% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| J.P. Morgan Healthcare Conference 2026 | Conference | 19 slides | Jan 15, 2026 |
| J.P. Morgan Healthcare Conference 2025 | Conference | 37 slides | January 2025 |
Financials
Annual, in KRW
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 425.1B | 373.0B | 319.7B | 281.7B | 245.2B | 211.0B | 204.6B | 182.4B | 182.1B | 124.2B |
| Cost of revenue | 91.6B | 85.9B | 73.5B | 62.8B | 64.4B | 62.3B | 60.6B | 51.0B | 40.0B | 29.8B |
| Gross profit | 333.5B | 287.2B | 246.2B | 218.9B | 180.8B | 148.8B | 143.9B | 131.4B | 142.1B | 94.4B |
| Research and development | 11.7B | 9.21B | 11.0B | 15.1B | 12.6B | 15.7B | 7.75B | 6.92B | 4.06B | |
| Selling, general and administrative | 63.9B | 102.7B | 109.4B | 94.5B | 63.2B | 49.8B | 61.6B | 61.0B | 31.0B | 25.3B |
| Operating income | 200.9B | 147.8B | 106.2B | 94.5B | 96.2B | 77.4B | 68.1B | 85.6B | 102.4B | 63.2B |
| Depreciation and amortization | 19.7B | 10.5B | 13.9B | 14.0B | 14.3B | 10.7B | 9.49B | 7.49B | 6.76B | 3.92B |
| EBITDA | 220.6B | 158.3B | 120.1B | 108.5B | 110.5B | 88.1B | 77.6B | 93.1B | 109.1B | 67.2B |
| Interest expense | 1.13B | 1.18B | 2.94B | 3.11B | 3.72B | 3.66B | 0 | 0 | 0 | 0 |
| Income before tax | 196.8B | 165.2B | 133.3B | 73.1B | 89.0B | 69.3B | 69.7B | 99.5B | 103.5B | 64.3B |
| Income tax | 9.18B | 28.3B | 24.0B | 19.4B | 23.9B | 22.2B | 13.4B | |||
| Net income | 140.9B | 135.8B | 93.1B | 57.3B | 57.7B | 42.0B | 44.6B | 69.7B | 72.8B | 43.3B |
| Earnings per share, basic | 13,039.71 | 12,347.56 | 8,299.88 | 4,856.26 | 4,744.19 | 3,352.51 | 3,561.65 | 5,496.31 | 5,641.36 | 4,418.41 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 209.7B | 130.1B | 106.0B | 2.46M | 294.1B | 62.4B | 15.2B | 29.0B | 31.3B | 64.9B |
| Short-term investments | 329.1B | 293.0B | 375.9B | 392.2B | 258.0B | 536.8B | 553.6B | 572.6B | 564.4B | 39.3B |
| Receivables | 75.0B | 48.4B | 44.1B | 53.2B | 28.4B | 28.0B | 38.3B | 56.1B | 66.3B | 32.3B |
| Inventory | 55.8B | 42.6B | 34.3B | 26.9B | 27.4B | 23.2B | 28.9B | 21.9B | 15.5B | 13.5B |
| Current assets | 679.4B | 522.9B | 567.8B | 617.9B | 616.1B | 668.4B | 640.9B | 684.8B | 679.4B | 151.3B |
| Property, plant and equipment | 151.0B | 134.7B | 120.5B | 95.7B | 76.9B | 69.8B | 60.6B | 59.0B | 58.8B | |
| Goodwill | 78.1B | 86.2B | 83.3B | 84.6B | 95.4B | 92.5B | 76.2B | 75.5B | 55.1B | 55.1B |
| Total assets | 1.08T | 939.4B | 929.3B | 1.05T | 1.01T | 956.3B | 894.7B | 918.3B | 820.9B | 294.3B |
| Accounts payable | 5.99B | 4.35B | 2.95B | 4.81B | 6.86B | 4.78B | 5.69B | 6.06B | 4.72B | 3.24B |
| Current liabilities | 93.0B | 61.1B | 57.4B | 177.3B | 54.0B | 43.8B | 37.6B | 23.0B | 22.7B | 19.9B |
| Long-term debt | 24.5B | 88.8B | 0 | 93.9B | 90.1B | 86.4B | 82.9B | 79.6B | 0 | |
| Total debt | 92.3B | 90.2B | 82.9B | 79.6B | ||||||
| Total liabilities | 96.7B | 98.6B | 149.6B | 257.7B | 232.7B | 209.7B | 195.2B | 190.5B | 125.2B | 41.5B |
| Shareholders' equity | 950.3B | 803.8B | 747.3B | 792.1B | 777.1B | 746.7B | 699.5B | 727.7B | 695.7B | 252.8B |
| Shares outstanding | 10.8M | 11.0M | 11.2M | 11.8M | 12.2M | 12.5M | 12.5M | 12.7M | 12.9M | 9.79M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 150.1B | 149.1B | 117.7B | 80.6B | 85.9B | 74.3B | 77.0B | 65.8B | 64.2B | 45.1B |
| Capital spending | -29.5B | -33.3B | -40.6B | -32.8B | -23.9B | -17.0B | -12.3B | -9.10B | -6.34B | -16.1B |
| Free cash flow | 120.5B | 115.7B | 77.2B | 35.6B | 37.5B | 29.1B | 64.7B | 56.7B | 57.8B | 29.0B |
| Cash from investing | 42.4B | 43.2B | -191.8B | 180.1B | -25.3B | -979.3M | -32.2B | -555.3B | -53.9B | |
| Cash from financing | -172.1B | -187.1B | -51.4B | -36.0B | -1.84B | -90.3B | -35.6B | 457.6B | 3.13B | |
| Dividends paid | 0 | -105.9M | ||||||||
| Share buybacks | -1.32B | -166.3B | -122.4B | -44.5B | -34.6B | -46.2B | -35.6B | 357.9B | 4.23B | |
| Change in cash | 79.6B | 24.1B | -25.8B | -162.4B | 231.8B | 47.1B | -13.7B | -2.27B | -33.6B | -5.63B |
Cap table
Built by 6ix from Hugel, Inc.’s releases
- Common shares
- 10,803,292
- Fully diluted
- 10,803,292
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 10,803,292 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 10,803,292 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carrie Strom | Chief Executive Officer · Since at least Oct 13, 2025 |
Log in to ask 6ix AI your own questions about Hugel, Inc.